story of the week
Safety and Efficacy of Ipatasertib Plus Carboplatin, Carboplatin and Paclitaxel, or Capecitabine and Atezolizumab in Patients With Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer
Oncologist 2023 Apr 06;[EPub Ahead of Print], Y Yuan, SE Yost, Y Cui, C Ruel, M Murga, A Tang, N Martinez, D Schmolze, J Waisman, N Patel, L Vora, L Tumyan, M Bozoghlanian, D Stewart, PH FrankelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.